Prentiss Christopher B

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Adamas Pharmaceuticals Inc (ADMS)

Transaction date 20 Dec 2018

Planned sale

Price

288.44

Quantity 44,726 -40.0%

Value US$4,943,758

Comments Filing

Adamas Pharmaceuticals Inc (ADMS)

Transaction date 21 Mar 2018

Sale

Price

457.29

Quantity 79,152 +40.4%

Value US$3,113,299

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2018-12-26	2018-12-20	Adamas Pharmaceuticals Inc (ADMS)	PlS Planned sale	44,726 -40.0% 288.44 US$4,943,758	44,726 -40.0%	288.44	US$4,943,758
2018-03-22	2018-03-21	Adamas Pharmaceuticals Inc (ADMS)	S Sale	79,152 +40.4% 457.29 US$3,113,299	79,152 +40.4%	457.29	US$3,113,299